Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naoyuki Kanzaki
Observed names:
Kanzaki, N.,
Kanzaki, Naoyuki,
N Kanzaki,
N. Kanzaki,
NAOYUKI KANZAKI
Institution:
Takeda (Japan)
Observed institutions:
Kagoshima University,
Takeda (Japan),
The University of Osaka
OpenAlex ID:
A5090477990
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
1999
·
Masanori Baba
, Osamu Nishimura
, et al.
·
Proceedings of the National Academy of Sciences
·
812
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
2003
·
Takahito Hara
, Jun-ichi Miyazaki
, et al.
·
PubMed
·
492
T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer
2003
·
Hirokazu Tamamura
, Akira Hori
, et al.
·
FEBS Letters
·
312
PDF
Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist
2010
·
Nobuyuki Negoro
, Shinobu Sasaki
, et al.
·
ACS Medicinal Chemistry Letters
·
257
Discovery of Novel, Potent, and Selective Small-Molecule CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Evaluation of Anilide Derivatives with a Quaternary Ammonium Moiety
2000
·
Mitsuru Shiraishi
, Yoshio Aramaki
, et al.
·
Journal of Medicinal Chemistry
·
199
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety
2004
·
Masaki Seto
, Naoki Miyamoto
, et al.
·
Bioorganic & Medicinal Chemistry
·
116
TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans
2005
·
Masanori Baba
, Katsunori Takashima
, et al.
·
Antimicrobial Agents and Chemotherapy
·
115
Design, Synthesis, and Biological Activity of Potent and Orally Available G Protein-Coupled Receptor 40 Agonists
2011
·
Shinobu Sasaki
, Shuji Kitamura
, et al.
·
Journal of Medicinal Chemistry
·
98
Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety
2006
·
Masaki Seto
, Katsuji Aikawa
, et al.
·
Journal of Medicinal Chemistry
·
96
Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent
2012
·
Nobuyuki Negoro
, Shinobu Sasaki
, et al.
·
Journal of Medicinal Chemistry
·
85
Discovery of a Piperidine-4-carboxamide CCR5 Antagonist (TAK-220) with Highly Potent Anti-HIV-1 Activity
2006
·
Shinichi Imamura
, Takashi Ichikawa
, et al.
·
Journal of Medicinal Chemistry
·
80
Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists
2012
·
Nobuyuki Negoro
, Shinobu Sasaki
, et al.
·
Journal of Medicinal Chemistry
·
69
Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach
2014
·
Hiroshi Nara
, Kenjiro Sato
, et al.
·
Journal of Medicinal Chemistry
·
68
Discovery of the First Potent and Orally Available Agonist of the Orphan G-Protein-Coupled Receptor 52
2014
·
Masaki Setoh
, Naoki Ishii
, et al.
·
Journal of Medicinal Chemistry
·
68
Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activity of 1-Benzothiepine 1,1-Dioxide and 1-Benzazepine Derivatives Containing a Tertiary Amine Moiety
2004
·
Masaki Seto
, Yoshio Aramaki
, et al.
·
Chemical and Pharmaceutical Bulletin
·
68
PDF
Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach
2016
·
Hiroshi Nara
, Akira Kaieda
, et al.
·
Journal of Medicinal Chemistry
·
65
Analysis of Binding Sites for the New Small-Molecule CCR5 Antagonist TAK-220 on Human CCR5
2005
·
Masao Nishikawa
, Katsunori Takashima
, et al.
·
Antimicrobial Agents and Chemotherapy
·
64
Highly Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by TAK-220, an Orally Bioavailable Small-Molecule CCR5 Antagonist
2005
·
Katsunori Takashima
, Hiroshi Miyake
, et al.
·
Antimicrobial Agents and Chemotherapy
·
63
Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site
2014
·
Hiroshi Nara
, Kenjiro Sato
, et al.
·
Bioorganic & Medicinal Chemistry
·
57
Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes
2012
·
Satoshi Mikami
, Shuji Kitamura
, et al.
·
Journal of Medicinal Chemistry
·
53
Synthesis of 1-Benzothiepine and 1-Benzazepine Derivatives as Orally Active CCR5 Antagonists
2004
·
Yoshio Aramaki
, Masaki Seto
, et al.
·
Chemical and Pharmaceutical Bulletin
·
50
PDF
CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives
2004
·
Shinichi Imamura
, Youichi Nishikawa
, et al.
·
Bioorganic & Medicinal Chemistry
·
47
High homology between 6-aminohexanoate-cyclic-dimer hydrolases of Flavobacterium and Pseudomonas strains
1989
·
K Tsuchiya
, S Fukuyama
, et al.
·
Journal of Bacteriology
·
47
Orally Active CCR5 Antagonists as Anti-HIV-1 Agents 2: Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N-Oxide Moiety
2004
·
Masaki Seto
, Yoshio Aramaki
, et al.
·
Chemical and Pharmaceutical Bulletin
·
42
PDF
Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists
2018
·
Takuto Kojima
, Michiyo Mochizuki
, et al.
·
Bioorganic & Medicinal Chemistry
·
38
Show more works
View as search
Works count:
59
Citation count:
3,842
H-index:
30
I10-index:
40
Year
Topic
Type